Achievement of Therapeutic Goals with Low-Dose Imiglucerase in Gaucher Disease: A Single-Center Experience
Gaucher disease, a lysosomal storage disorder, is a multisystem disorder with variable and unpredictable onset and severity. Disease-specific enzyme replacement therapy (ERT) has been shown to reverse or ameliorate disease-specific hepatosplenomegaly and anemia and thrombocytopenia. ERT also impacts...
Saved in:
Main Authors: | Irina Tukan, Irith Hadas-Halpern, Gheona Altarescu, Ayala Abrahamov, Deborah Elstein, Ari Zimran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/151506 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey
by: Ari Zimran, et al.
Published: (2025-01-01) -
Obstacles to Early Diagnosis of Gaucher Disease
by: Nishimura S, et al.
Published: (2025-01-01) -
Esplenomegalia gigante por enfermedad de Gaucher
by: Raysy Sardiñas Ponce, et al.
Published: (2021-12-01) -
La douloureuse histoire du forçat innocent Philibert Gaucher
by: Jean-Lucien Sanchez
Published: (2011-03-01) -
Echocardiographic Assessment of Left Ventricular Function in Type 1 Gaucher's Disease
by: Mirta Koželj, et al.
Published: (2010-01-01)